WELCOME TO
DISEASE BIOLOGY AND CELLULAR IMMUNOLOGY LAB
The scientist is not a person who gives the right answers, he’s one who asks the right questions.”
EDUCATION
WORK EXPERIENCE
-
Ph.D. in Human Medicine, University of Marburg, Marburg, Germany
-
M.Sc. in Microbiology, North Maharashtra University, Jalgaon, India
-
B.Sc. in Microbiology, North Maharashtra University, Jalgaon, India
​
​
ADMINISTRATIVE EXPERIENCE
INTERNATIONAL FELLOWSHIPS
-
Alexander von Humboldt Fellow (Experienced Researcher): Research Center Borstel, Germany (2017)
-
EMBO Fellow: Karolinska Institute, Sweden (2014)
-
Swiss National Science Fellow: University of Zurich, Switzerland (2014)
-
EMBO Fellow: University of Ulm, Germany (2012)
-
Swedish Institute Fellow: University of Lund, Sweden (2010)
-
JSPS Fellow: NARA Institute for Science and Technology, Japan (2006)
-
Dean (2020-Present), International Relations, IIT Indore
-
Dean (2016-2018), School of Biotechnology, KIIT University, Bhubaneswar
-
Associate Dean (2012-2016), School of Biotechnology, KIIT University, Bhubaneswar
-
Professor (2019-Present), Biosciences & Biomedical Engineering, IIT Indore, India.
-
Visiting Professor, Leibniz Lung Centre, Borstel, Germany
-
Associate Professor (2018-2019), Biosciences & Biomedical Engineering, IIT Indore, India.
-
Professor (2015-2018), School of Biotechnology, KIIT University,Bhubaneswar, India.
-
Associate Professor (2010-2014), School of Biotechnology, KIIT University, Bhubaneswar, India.
-
Assistant Professor (2009-2010), School of Biotechnology, KIIT University, Bhubaneswar, India.
-
Post Doctoral Fellow (2007-2008), European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
-
Post Doctoral Fellow (2006 - 2007), Max-Planck Institute for Infection Biology, Berlin, Germany.
-
Post Doctoral Associate (2004-2006), Department of Medicine, Infectious Diseases,University of Florida, Florida, USA.
Honours
​
-
DAAD Research Ambassador, Germany
-
Ambassador, Association of Commonwealth Universities, UK
-
Steering and Executive Council Member, India-Europe Heritage Network
-
Member, Project Advisory Committee Life Sciences and Medical Biology, International Cooperation Division, DST
-
Member, EMEQ Task Force Committee, SERB, GoI
-
Member, DST-FIST Committee, DST, GoI
-
Expert member for Indo-Norway bilateral program on antimicrobial resistance, ICMR, GoI
-
Expert member for Indo-German bilateral program on antimicrobial resistance, ICMR, GoI
-
DBT Nominee, Institute Biosafety Committee
-
Member, Screening Committee, Nobel Laureate Meet Lindau
-
PAC Member, SERB-POWER, GoI
-
PAC, Special Invitee, SERB-SUPRA, GoI
-
PAC Member, SERB-SURE, GoI
-
International Expert member, Swiss National Science Foundation, Switzerland
-
International Expert member, Executive Research Committee, Poland
-
Scientific Advisory Committee Member, Mahatma Gandhi Central University, Bihar
-
Scientific Advisory Committee Member, SRTM University, India
-
Member, Board of Mentor for start-ups, Atal Incubation Centre-Prestige, Indore
Prof. (Dr.) Avinash Sonawane, FRSB, FMAS
ABOUT PI
Professor
Department of Biosciences and Biomedical Engineering,
Indian Institute of Technology Indore (IIT Indore)
Madhya Pradesh, India
Alexander von Humboldt Visiting Professor
Leibniz Lung Centre
Leibniz Center for Medicine and Biosciences, Borstel, Germany
​
Dean, International Relations, IIT Indore
ABOUT US
​
+91-7324-306 745
​
https://twitter.com/LabSonawane
​
Facebook:
https://www.facebook.com/avinash.sonawane.754
Linkedin:
https://www.linkedin.com/in/avinash-sonawane-59b9b826b/
​
​
Welcome to the Disease Biology and Cellular Immunology research group at Indian Institute of Technology Indore. Our research is broadly focussed on understanding the molecular mechanisms of Mycobacterium tuberculosis pathogenesis in bone marrow stem cells and lung macrophages, host immune evasion mechanisms, development of active small drug compounds and antimicrobial peptides, and targeted drug delivery systems to improve tuberculosis therapy. In addition to this we are also developing novel asparaginase enzyme based therapy for the treatment of primary and relapsed acute lymphatic leukemia (ALL).
